Cargando…

Gain of Function (GOF) Mutant p53 in Cancer—Current Therapeutic Approaches

Continuous development of personalized treatments is undoubtedly beneficial for oncogenic patients’ comfort and survival rate. Mutant TP53 is associated with a worse prognosis due to the occurrence of metastases, increased chemoresistance, and tumor growth. Currently, numerous compounds capable of p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roszkowska, Katarzyna A., Piecuch, Aleksandra, Sady, Maria, Gajewski, Zdzisław, Flis, Sylwia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654280/ https://www.ncbi.nlm.nih.gov/pubmed/36362074 http://dx.doi.org/10.3390/ijms232113287

Ejemplares similares

Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target
por: Schulz-Heddergott, Ramona, et al.
Publicado: (2018)

Gain-of-Function Mutations in p53 in Cancer Invasiveness and Metastasis
por: Roszkowska, Katarzyna A., et al.
Publicado: (2020)

GOF Mutant p53 in Cancers: A Therapeutic Challenge
por: Dolma, Lobsang, et al.
Publicado: (2022)

A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis
por: Yue, Xuetian, et al.
Publicado: (2016)

Depleting stabilized GOF mutant p53 proteins by inhibiting molecular folding chaperones: a new promise in cancer therapy
por: Alexandrova, Evguenia M, et al.
Publicado: (2017)

Transcriptome profiling identifies genes and pathways deregulated upon floxuridine treatment in colorectal cancer cells harboring GOF mutant p53
por: Datta, Arindam, et al.
Publicado: (2016)

Content of Health-Promoting Fatty Acids in Commercial Sheep, Cow and Goat Cheeses
por: Szterk, Arkadiusz, et al.
Publicado: (2022)

Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches
por: Alvarado-Ortiz, Eduardo, et al.
Publicado: (2021)

Oncogenomic Approaches in Exploring Gain of Function of Mutant p53
por: Donzelli, Sara, et al.
Publicado: (2008)

mBio Addresses the Pause in Gain-of-Function (GOF) Experiments Involving Pathogens with Pandemic Potential (PPP)
por: Casadevall, Arturo, et al.
Publicado: (2014)

Vagueness and Costs of the Pause on Gain-of-Function (GOF) Experiments on Pathogens with Pandemic Potential, Including Influenza Virus
por: Imperiale, Michael J., et al.
Publicado: (2014)

The Irrationality of GOF Avian Influenza Virus Research
por: Wain-Hobson, Simon
Publicado: (2014)

Gain-of-function mutant p53: history and speculation
por: Bargonetti, Jill, et al.
Publicado: (2019)

Addiction of lung cancer cells to GOF p53 is promoted by up-regulation of epidermal growth factor receptor through multiple contacts with p53 transactivation domain and promoter
por: Vaughan, Catherine A., et al.
Publicado: (2016)

Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain of Function (GOF) Mutations—10 Children and Review of the Literature
por: Deyà-Martínez, Angela, et al.
Publicado: (2022)

Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53
por: Vikhanskaya, Faina, et al.
Publicado: (2007)

Wild-type p53 oligomerizes more efficiently than p53 hot-spot mutants and overcomes mutant p53 gain-of-function via a “dominant-positive” mechanism
por: Walerych, Dawid, et al.
Publicado: (2018)

Selective targeting of p53 gain-of-function mutants in cancer
por: Padmanabhan, Achuth
Publicado: (2018)

Gain-of-function mutant p53 in cancer progression and therapy
por: Zhang, Cen, et al.
Publicado: (2020)

Editor's Note on ‘Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53’
Publicado: (2023)

Gain of function of mutant p53: R282W on the peak?
por: Zhang, Y, et al.
Publicado: (2016)

Context is everything: extrinsic signalling and gain-of-function p53 mutants
por: Amelio, Ivano, et al.
Publicado: (2020)

Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis
por: Stein, Yan, et al.
Publicado: (2019)

Ruxolitinib Controls Lymphoproliferation and Diabetes in a STAT3-GOF Patient
por: Wegehaupt, Oliver, et al.
Publicado: (2020)

p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo
por: Alexandrova, Evguenia M, et al.
Publicado: (2017)

Cytoplasmic gain-of-function mutant p53 contributes to inflammation-associated cancer
por: Bellazzo, Arianna, et al.
Publicado: (2015)

Oncogenic Gain of Function in Glioblastoma Is Linked to Mutant p53 Amyloid Oligomers
por: Pedrote, Murilo M., et al.
Publicado: (2020)

Acquisition of aneuploidy drives mutant p53-associated gain-of-function phenotypes
por: Redman-Rivera, Lindsay N., et al.
Publicado: (2021)

Regulation of miRNAs Expression by Mutant p53 Gain of Function in Cancer
por: Madrigal, Tzitzijanik, et al.
Publicado: (2021)

P53 Gain-of-Function Mutants and Steroids in Ovarian Cancer Cell Metastasis
por: Candelaria, Nicholes, et al.
Publicado: (2021)

Differential chromatin accessibility landscape of gain-of-function mutant p53 tumours
por: Dhaka, Bhavya, et al.
Publicado: (2021)

Ledipasvir/Sofosbuvir Eradicates Hepatitis C in an Immunodeficient STAT3-GOF Patient
por: Thalhammer, Julian, et al.
Publicado: (2021)

The Gain of Function of p53 Mutant p53S in Promoting Tumorigenesis by Cross-talking with H-RasV12
por: Jia, Shuting, et al.
Publicado: (2012)

Stress-Induced Phosphaturia in Weaned Piglets
por: Habich, Malgorzata, et al.
Publicado: (2020)

Regulators of Oncogenic Mutant TP53 Gain of Function
por: Yamamoto, Satomi, et al.
Publicado: (2018)

Regulation of Nucleotide Metabolism by Mutant p53 Contributes to its Gain-of-Function Activities
por: Kollareddy, Madhusudhan, et al.
Publicado: (2015)

Control of Nucleotide Metabolism Enables Mutant p53’s Oncogenic Gain-of-Function Activity
por: Schmidt, Valentina, et al.
Publicado: (2017)

Statistical power estimation dataset for external validation GoF tests on EVT distribution
por: Reghenzani, Federico, et al.
Publicado: (2019)

Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF Patients
por: Bloomfield, Marketa, et al.
Publicado: (2021)

NLRC4 GOF Mutations, a Challenging Diagnosis from Neonatal Age to Adulthood
por: Bardet, Juliette, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ekla33a1o813ejqispg93he3lk